Tracheal or bronchial proximal stenoses occur as complications in 20–30% of lung cancers, resulting in a dramatic alteration in quality of life and poor prognosis. Bronchoscopic management of these obstructions is based on what are known as “thermal” techniques for intraluminal stenosis and/or placement of tracheal or bronchial prostheses for extrinsic compressions, leading to rapid symptom palliation in the vast majority of patients. This invasive treatment should only be used in cases of symptomatic obstructions and in the presence of viable bronchial tree and downstream parenchyma. This review aims to clarify 1) the available methods for assessing the characteristics of stenoses before treatment, 2) the various techniques available inclu...
Palliative airway treatments are essential to improve quality and length of life in lung cancer pati...
Number 1 in this Series Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon...
Mediastinal lymph node involvement is present in 26\%-38\% of patients with non-small-cell lung canc...
AbstractThe natural of lung cancer history includes frequent airways involvement by the tumour deter...
Central airway stenosis may be a manifestation of benign or malignant lesions and can be a life thre...
Background: There are no data regarding the factors influencing the choice of therapeutic bronchosco...
Educational Aims To highlight the various methods of interventional bronchoscopy.; To inform about t...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Background:Bronchoscopic treatment is 1 of the treatment ...
BACKGROUND Interventional bronchoscopy is effective in the management of patients with symptomati...
More than half of primary lung cancers are not resectable at diagnosis and 40% of deaths may be sec...
peer reviewedDuring recent years the endobronchial prostheses has become an essential part of the th...
Lung cancer is the leading cause of cancer related deaths worldwide. As a result of the increasing u...
Lung cancer is the leading cause of cancer-related death worldwide and surgical lobectomy remains th...
Palliative airway treatments are essential to improve quality and length of life in lung cancer pati...
Background: Tracheobronchial mucoepidermoid carcinoma (MEC) is a rare airway tumor in adults for whi...
Palliative airway treatments are essential to improve quality and length of life in lung cancer pati...
Number 1 in this Series Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon...
Mediastinal lymph node involvement is present in 26\%-38\% of patients with non-small-cell lung canc...
AbstractThe natural of lung cancer history includes frequent airways involvement by the tumour deter...
Central airway stenosis may be a manifestation of benign or malignant lesions and can be a life thre...
Background: There are no data regarding the factors influencing the choice of therapeutic bronchosco...
Educational Aims To highlight the various methods of interventional bronchoscopy.; To inform about t...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Background:Bronchoscopic treatment is 1 of the treatment ...
BACKGROUND Interventional bronchoscopy is effective in the management of patients with symptomati...
More than half of primary lung cancers are not resectable at diagnosis and 40% of deaths may be sec...
peer reviewedDuring recent years the endobronchial prostheses has become an essential part of the th...
Lung cancer is the leading cause of cancer related deaths worldwide. As a result of the increasing u...
Lung cancer is the leading cause of cancer-related death worldwide and surgical lobectomy remains th...
Palliative airway treatments are essential to improve quality and length of life in lung cancer pati...
Background: Tracheobronchial mucoepidermoid carcinoma (MEC) is a rare airway tumor in adults for whi...
Palliative airway treatments are essential to improve quality and length of life in lung cancer pati...
Number 1 in this Series Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon...
Mediastinal lymph node involvement is present in 26\%-38\% of patients with non-small-cell lung canc...